Adult Vaccinations

In the midst of a pandemic with the fall and winter seasons upon us, the fear of a “twin-demic” involving increasing cases of both COVID-19 and influenza are of critical concern. Will there be enough resources to provide care for these two serious illnesses and will some patients actually get both at the same time? The reason to vaccinate against influenza while we await the availability of a safe and effective coronavirus vaccine has never been so important. Yet, there is a significant amount of vaccine hesitancy. How much is there? To answer that question, Santibanez et al (10.1542/peds.2020-007609) examined the 2018 and 2019 National Immunization Survey on Influenza (NIS-Flu), which included a 6-question survey on vaccine hesitancy. Their results are shared in detail in a study we are early releasing this month in our journal. Over 35,000 parents were surveyed to determine if they were vaccine hesitant, why that might be, and whether they had vaccinated their child over the past ye...

The Department of Health is currently out of the flu vaccine — which they said was due to a surge in demand as well as supply chain disruption due to the cancellation of British Airways flights — so “all walk-in service for obtaining flu vaccines for the following weeks are canceled.” In providing today’s Covid results, a Government spokesperson said, “The Department of Health is advising members of the public that they are currently out of the influenza [flu] vaccine. This is due to an atypical surge in demand for the vaccine as well as supply chain disruption due to the cancellation of British Airways flights. “Therefore all walk-in service for obtaining flu vaccines for the following weeks are canceled. This was previously scheduled to take place at the Hamilton Health Centre. “The Department of Health is working to reroute our incoming shipment of the vaccine, which was scheduled to arrive on a British Airways flight later this month.” Related Stories Read More About #He...

© iStock/FatCamera Valeria Fava, Isabella Mori, Mariano Votta, and Maira Cardillo of Cittadinanzattiva have curated the results of a civic survey on the supply of influenza vaccine doses across Italy. Some early vaccination campaigns began between 1 October and 15 October; and some of these will be extended until 31 January 2021. However, while there has been a percentage increase in the purchase of influenza vaccines up to three figures, there remains a serious lack of vaccines in pharmacies across Italy. Cittadinanzattiva’s civic survey was conducted to better understand this situation. It collected information from the following 10 Italian regions: Abruzzo, Campania, Emilia Romagna, Lazio, Marche, Puglia, Sicilia, Toscana, Umbria, and Valle d’Aosta. Some of these regions have demonstrated a significant increase in available doses, such as Puglia (+320%), Lazio (+112%), Tuscany (+68%), and Sicily (+65%), while others show less marked increases, such as Campania and Emilia (+20...

BANDAR SERI BEGAWAN, Nov 2 (Borneo Bulletin/ANN): The batch of Vaxigrip Tetra used in the Republic of Korea has not been distributed in any other country and therefore has never been imported into Brunei, the Ministry of Health (MoH) said yesterday. The MoH stated this in a release following reports of deaths in the Republic of Korea due to mass influenza immunisation. The MoH added while Brunei imports and uses Vaxigrip Tetra manufactured by Sanofi Pasteur France, which is one of the seven brands of influenza vaccines used in the Republic of Korea, the batch of Vaxigrip Tetra used in the Republic of Korea has never been in Brunei. The Korea Disease Control and Prevention Agency (KDCA) has investigated the matter and has reported no direct link between the deaths with the usage of the affected influenza vaccine brands. Most deaths involved people in their 70s and 80s. The autopsies showed that deaths were from other serious chronic health conditions like cardiovascular and cerebral ...

A global leader in influenza prevention, Seqirus presented today absolute efficacy data on the company’s cell-based quadrivalent influenza vaccine (QIVc) from a randomized controlled trial (RCT) which met its primary endpoint in children and adolescents between ≥2 to <18 years of age over three influenza seasons. 3D influenza/CDC This study represents the first absolute efficacy study of a cell-based seasonal influenza vaccine in this population. “Annual influenza vaccination is extremely important,” said Jonathan Edelman, MD, Vice President, Clinical Development at Seqirus and study author. “This study reinforces our commitment to addressing this very serious public health threat by utilizing our advanced influenza vaccine technologies to help protect as many people as possible, including populations such as children between the ages of 2 and 18.” Standard influenza vaccines are manufactured using the egg-based manufacturing process and may be subjected to egg-adapted cha...

MarketsandResearch.biz has published the latest market research study on Global Influenza Vaccine Market 2020 by Manufacturers, Type and Application, Forecast to 2025 combines market essential details, definitions, categorization, professional market study, and analysis of significant features. The report estimates the global Influenza Vaccine market share, competition landscape, market share, growth rate, future trends. The report presents an introduction and structure of the market where the worldwide market’s vital regional market demands are studied. Exhaustive investigation about current market trends, opportunities, challenges, and detailed competitive analysis of the industry players in the market has been given. The market report is segmented by, trends, latest analytics, top players, application usage, and various important geographical dividends. NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for...

October 24, 2020 1 min read Source/Disclosures Source: Campbell AP, et al. Abstract 178. Presented at: IDWeek; Oct. 21-25, 2020 (virtual meeting). Disclosures: Campbell reports no relevant financial disclosures. Please see the abstract for all other authors’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Data reported during IDWeek showed that the 2019-2020 influenza vaccine was 62% effective among children, including 55% effective against influenza B despite a poor match for circulating B viruses, researchers reported. For the first time in decades, influenza B viruses — which are more common among children th...

  JERUSALEM , Oct. 23, 2020 /PRNewswire/ -- BiondVax Pharmaceuticals  Ltd. (Nasdaq: BVXV), a pioneer in the development of a universal flu vaccine designed to provide protection against current, future, seasonal and pandemic influenza, today announced topline data from the Company's pivotal, phase 3 clinical trial of M-001 as a standalone universal flu vaccine candidate.   Results did not demonstrate a statistically significant difference between the vaccinated and placebo groups in reduction of flu illness and severity, and therefore failed to meet both the primary and secondary efficacy endpoints. The study's primary safety endpoint was met. "We are disappointed with these results, and I wish to thank the BiondVax team for their efforts, dedication, and passion over the past 15 years. Together we have endeavored to develop an innovative approach to a persistent global problem. I am especially grateful to each of the clinical trial participants, as well as th...

The province has purchased 77,000 doses of influenza vaccine and almost all have been distributed. A spokeswoman for the department of Health and Wellness says the vaccine has been distributed to pharmacies, family physician offices and public health nursing as well as to long-term care facilities and hospitals. The doses include 22,300 high dose influenza vaccine for those over 65 and 4,000 doses of Flumist. Public Health nursing started its clinics recently. Pharmacies have been administering the influenza vaccine over the past couple weeks. Chief public health officer Dr. Heather Morrison is strongly promoting the flu vaccine. “Getting a flu shot and washing your hands frequently is the best way to protect yourself from getting the flu or spreading the flu to those around you,” she says.  “All Islanders are encouraged to protect themselves and get immunized, especially those who are at a higher risk of becoming seriously ill from influenza, such as young children, elderly...

Seasonal influenza vaccine development and mass production may lead to future efforts targeted at developing and evaluating vaccine strategies for Covid-19, say researchers. Also Read - Areas Around UK Could Face Lockdown Due to 'Missed' COVID-19 Data; PM Facing Ruling Party Rebellion Over Curbs Imposed In the study, published in the Journal of the American College of Cardiology, the research team evaluated whether existing flu trial networks could offer primary and secondary prevention strategies for patients with cardiovascular disease at risk of complications from Covid-19. Also Read - New COVID-19 Recoveries Surpass New Cases, Daily Positivity Rate Down: Union Health Ministry The World Health Organisation (WHO) estimates that influenza kills as many as 6,50,000 people every year globally, citing influenza as a top 10 leading cause of death among people of all ages, especially those with one or more comorbidities like cardiovascular disease. Also Read - Ajay Devgn's C...

During the pandemic, it will be more important that everyone over 6 months of age get vaccinated against influenza so as not to use up limited medical resources on a preventable illness. Furthermore, influenza might potentiate the severity of COVID-19. Yet, many question the need for an annual vaccine. How effective is the flu vaccine? Campbell et al (10.1542/peds.2020-1368) studied this by looking at the effectiveness of the 2018-19 influenza vaccine that was targeted against three predicted strains of influenza A and B, but was not designed to target an antigenically drifted A (H3N2) strain that appeared to predominate in the second half of the flu season. The authors looked at 1792 hospitalized children at 7 hospitals between the ages of 6 months and 17 years and at 1944 children seen in their emergency departments during the 2018-2019 flu season. They obtained vaccine status from parental report in the ED, as well as state immunization registries or provider records for inpatients...

WiseGuyReports.com Publish A New Market Research Report on –“ Influenza Vaccine Market | Global Industry Analysis, Size, Share, Growth, Trends Forecasts 2025 ”. Influenza Vaccine Market 2020 Summary: – Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes moderate to severe illness, while the infection due to influenza B virus results in milder disease and affects pediatrics primarily. Human illness due to influenza C is rare. Influenza C illness might be due to subclinical cases. Hence, it does not cause epidemic diseases. Influenza has emerged as a severe health concern globally. The market encompasses both live attenuated as well as recombinant influenza vaccines for the prevention of influenza. The major factors that lead to the market gro...

October 03, 2020 3 min read Source/Disclosures Source: Healio Interviews Disclosures: Tirupathi reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Experts have expressed concern about a surge in COVID-19 cases during influenza season. We asked Infectious Disease News Editorial Board Member Raghavendra Tirupathi, MD, FACP, medical director for Keystone Infectious Diseases/HIV, chair of infection prevention at Summit Health and clinical assistant professor of medicine at Penn State University School of Medicine. about the clinical considerations in vaccinating patients with COVID-19 for influenza. Q:...

Fake news about the coronavirus can do real harm. Polygraph.info is spotlighting fact-checks from other reliable sources here​. Daily Debunk Claim:  The influenza vaccine Fluzone is more deadly than Covid-19. Vedict:  False Read the full story at:  Agence France-Presse   Social Media Disinfo Screenshot Circulating on social media:  Claim that there is a double standard in the response to H1N1 vs. COVID-19. Verdict:  Partly False Read the full story at:  USA Today   Factual Reads on Coronavirus COVID research updates: Tests reveal silent reinfections in hospital workers Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear. -- Nature, September 28 A layperson’s guide to how — and when — a Covid-19 vaccine could be authorized This story is based on interviews as well as on documents the drug makers have released detailing their clinical trial plans. -- Stat, September 28

The report is an all-inclusive research study of the global Flu Vaccine (Influenza Vaccine) Market taking into accounts the growth factors, recent trends, developments, opportunities, and competitive landscape. The Flu Vaccine (Influenza Vaccine) Market analyst and researchers have done a wide analysis of the global Flu Vaccine (Influenza Vaccine) Market with the help of research methodologies such as PESTLE and Porter’s Five Forces breakdown. They have provided exact and consistent market data and useful recommendations with an aim to help the players gain an insight into the overall current and upcoming market scenario. Request Sample Report @: https://ift.tt/2G83X4P Leading manufacturers of Flu Vaccine (Influenza Vaccine) Market: CSL GSK Sanofi Pasteur Mylan AstraZeneca Pfizer Johnson & Johnson The report presents a detailed competitive landscape along with a comprehensive analysis of the market share and size, product range, product innovation, technological advancem...

ROCHESTER, N.Y. (WROC) — Area health officials expressed the importance of getting a flu shot this year this fall as the pandemic wages on. “This year, in the midst of an ongoing pandemic, it is even more important to get vaccinated against influenza,” said Monroe County Public Health Commissioner Dr. Michael Mendoza. “Just as our community has come together to protect each other from COVID-19, we need to join forces to protect one another from the flu. Wear your mask, remain physically distant, wash your hands and get your flu shot today.” Flu shots are readily available at primary care offices, area pharmacies and several public clinics scheduled throughout the fall, officials say. Most health insurance providers cover the cost of the vaccination, and many locations offer discounted or free shots. Find a flu shot Rochester area Wegmans stores: Eastway Wegmans: outdoor clinic on 9/12 from 9 a.m. – 12 p.m. Marketplace Wegmans: outdoor clinic on 9/19 from 10 a.m. – 2 p.m. Medl...

Seasonal influenza vaccines will be administered for free in special centres that will be set up in every town, Health Minister Chris Fearne said. The government has procured 200,000 influenza vaccines with the first batch of 15,000 expected to arrive tomorrow, he added. Fearne was speaking in a recorded interview for TVM’s Xtra Sajf that will be broadcast this evening. The minister urged people to take the influenza vaccine this year as the health authorities try to stave off the impact of the seasonal flu at a time when the world is still grappling with COVID-19. The symptoms of seasonal flu are very similar to those of COVID, which may cause testing hubs to be overwhelmed. Apart from this, reducing the possibility of hospital admissions because of the influenza will lessen the burden on medical resources. Fearne said by 11 October, the influenza vaccine will start being administered for free to everyone who asks for it in specialised centres that will be set up in every town...

Receiving the influenza vaccine does not increase a person’s risk for contracting Covid-19 or worsen associated conditions or mortality, according to a study. The research, published in the Journal of Clinical and Translational Science, shows the flu vaccine is the single most important intervention to help stay healthy. Seasonal flu activity is unpredictable, and otherwise healthy people are hospitalised due to serious respiratory infection each year, the researchers said. It is even more important to receive the flu vaccination this year to help prevent a ‘twindemic’ of flu and Covid-19, they said. Researchers led by Joe Zein, a pulmonologist at Cleveland Clinic in the US, analysed over 13,000 patients tested for Covid-19 between early March and mid-April. They compared those who had received unadjuvanted influenza vaccines in the fall or winter of 2019 (4,138 patients) with those who did not receive the vaccine (9,082 patients). The study found that influenza vaccination was n...

(CKOM News Staff) By CKOM News Sep 22, 2020 10:39 AM With flu season fast approaching, the Saskatchewan government has increased its order of influenza vaccine. In a media release Tuesday, the government announced it had purchased 36.5 per cent more vaccine than it did in 2019 in hopes of meeting an expected rise in demand. As well, high-dose vaccine is available this year for personal care home residents who are 65 years of age or older. Long-term care residents in that age group are to receive the high-dose vaccine for a third straight year. “It is always a good idea to receive the influenza vaccination but it is particularly important during the (COVID-19) pandemic,” Dr. Saqib Shahab, Saskatchewan’s chief medical health officer, said in the release.

A worldwide leader in influenza prevention announced the publication of new real-world evidence (RWE) that demonstrated an MF59® adjuvanted, trivalent influenza vaccine (aTIV) was more effective than a standard-dose, non-adjuvanted trivalent seasonal vaccine in preventing influenza-related medical office visits and hospitalizations in seniors during the 2017-2018 influenza season in the USA. Adding MF59® adjuvant to an influenza vaccine is designed to enhance the immune response to the influenza strains contained in the vaccine in adults 65 years and older. The Seqirus study was published in Vaccines on August 7, 2020, assessed relative influenza vaccine effectiveness (rVE) of aTIV compared to non-adjuvanted seasonal influenza vaccines including high-dose trivalent vaccine, standard-dose quadrivalent vaccine, and standard-dose trivalent vaccine. The vaccines included in the economic burden analysis are the only influenza vaccines specifically indicated for patients 65 years and ol...